— Know what they know.
Not Investment Advice

UPB Earnings

Upstream Bio, Inc.
1W: -6.0% 1M: -22.2% 3M: -31.9% YTD: -80.7% 1Y: -70.9%
$5.04
+0.00 (+0.00%)
 
Weekly Expected Move ±6.0%
$4 $5 $5 $5 $6
NASDAQ · Healthcare · Biotechnology · Tech Score Strong Sell · Power 30 · $274.3M mcap · 20M float · 3.04% daily turnover · Short 33% of daily vol
Last Earnings 2026-08-11
EPS
$-0.73
▼ Miss -0.6%
Revenue
$773K
▲ Beat +37.7%
Next Earnings 2026-11-04
EPS Estimate
$-0.73
Range: $-0.92 - $-0.46
Revenue Estimate
$524K
6 analysts

Estimate vs Actual

Earnings Surprise History

1/10
EPS Beats
8/10
Revenue Beats
10%
EPS Beat Rate
80%
Rev Beat Rate

Wall Street Forward Estimates

Quarterly
Annual

Estimate Revisions

Recent Revisions
DatePeriodFiscal DateEPS OldEPS NewChangeRev OldRev New
2026-09-28 quarter 2026-06-30 $-0.73 $-0.74 ▼ 0.01 $561,375 $431,143
2026-09-16 annual 2025-12-31 $-2.60 $-2.60 — $2,664,571 $2,681,000
2026-09-16 quarter 2025-12-31 $-0.73 $-0.72 ▲ 0.02 $584,000 $603,167
2026-09-09 annual 2028-12-31 $-2.88 $-2.88 — $4,162,200 $4,162,254
2026-09-09 annual 2026-12-31 $-2.87 $-2.87 — $2,707,714 $2,707,725
2026-09-09 annual 2027-12-31 $-2.76 $-2.76 — $1,634,800 $1,634,763
2026-09-09 quarter 2026-09-30 $-0.73 $-0.73 — $522,499 $522,455
2026-09-09 quarter 2027-09-30 $-0.66 $-0.66 — $410,000 $410,237
2026-09-09 quarter 2027-06-30 $-0.75 $-0.75 — $406,000 $406,176
2026-09-09 quarter 2027-03-30 $-0.76 $-0.76 — $402,000 $402,154
2026-09-09 quarter 2026-12-30 $-0.73 $-0.73 — $524,000 $524,057
2026-09-09 quarter 2027-12-30 $-0.67 $-0.67 — $414,500 $414,340
2026-09-08 quarter 2026-03-31 $-0.75 $-0.74 ▲ 0.01 $1,027,667 $623,400
2026-09-04 annual 2030-12-31 $-2.73 $-2.90 ▼ 0.17 $72,804,750 $62,793,250
2026-09-04 annual 2029-12-31 $-3.09 $-3.21 ▼ 0.12 $11,651,500 $9,709,250
Earnings Call Transcripts
No transcripts available.

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms